Nile Basin Initiative definition

Nile Basin Initiative or “NBI” means the transitional arrangement established by the Nile Basin States at the meeting of their Council of Ministers held in Dar-es-Salaam, Tanzania, on 22nd February, 1999, to foster cooperation and sustainable development of the Nile River for the benefit of the inhabitants of those countries;
Sample 1Sample 2Sample 3
Nile Basin Initiative means the framework launched in February 1999 to provide an institutional mechanism, a shared vision, and a set of agreed policy guidelines through which the Riparian States (as hereinafter defined) can cooperatively develop the resources of the Nile Basin to fight poverty and promote socio-economic development in the region.
Sample 1
Nile Basin Initiative means the institution established pursuant to the NBI Instruments (as hereinafter defined), and invested, on a transitional basis, with legal personality to perform all the functions entrusted to it, or any successor thereto;
Sample 1

Examples of Nile Basin Initiative in a sentence

  • The opinions expressed in these Media Reports in no way reflect the views of the Nile Basin Initiative and are presented for informational purposes only.

  • Disclaimer: The Weekly Nile Basin Media Radar is compiled by the Communication Office of the Nile Basin Initiative Secretariat in Entebbe, Uganda.

  • Therefore, the Nile Basin Initiative, in its journey of enabling socio-economic development in the Nile Basin region, has endeavoured to ensure environmental and social safeguards are considered in its river basin planning and development actions.

  • Nile Basin Initiative (NBI) has developed the SEF instead of a comprehensive Stakeholder Engagement Plan (SEP) at this point in time due to the fact that detailed information that would form the basis for developing a comprehensive SEP is still being put together and the available information is yet to be confirmed through on going planning and stakeholder engagement process.

  • The Nile Basin Initiative is currently addressing the issue of equitable utilization of the common Nile Basin water resources.The Nile Basin Initiative seeks to harness the tremendous potential of the Nile for the benefit of the people of the Basin, both for now and for generations to come.

  • Disclaimer: The Daily Nile Basin Media Radar is compiled by the Communication Office of the Nile Basin Initiative Secretariat in Entebbe, Uganda.

  • To implement these programs, the following year the Nile-COM ministers agreed to establish the Nile Basin Initiative (NBI) as a transitional institutional arrangement.

  • The Nile Basin Initiative (NBI) is a partnership of the riparian states of the Nile.

  • The Nile Basin Initiative (NBI) is an inter-governmental organization initiated and led bythe Nile riparian countries to promote joint development, protection and management of the common Nile River Basin water resources.

  • TAMP will complement the wider programmes and projects of the Nile Basin Initiative and Lake Victoria Environmental Management Programme, with the ability to focus on land resources and agricultural ecosystems and provide greater attention to local community and district action.


More Definitions of Nile Basin Initiative

Nile Basin Initiative or “NBI” means the transitional arrangement established by the Nile Basin States at the meeting of their Council of Ministers held in Dar-es-Salaam, Tanzania, on 22nd February, 1999, to foster cooperation and sustainable development of the Nile River for the benefit of the inhabitants of those countries (NBI Act, 2002). According to the NBI Act (2002), The NBI shall have the capacity, within Uganda, of a body corporate with perpetual succession, and with power to acquire, hold, manage and dispose of movable and immovable corporate property, and to sue and be sued in its own name.
Sample 1

Related to Nile Basin Initiative

  • Mobile crisis outreach team means a crisis intervention service for minors or families of minors experiencing behavioral health or psychiatric emergencies.

  • Nuclear fuel cycle-related research and development activities means those activities which are specifically related to any process or system development aspect of any of the following: - conversion of nuclear material, - enrichment of nuclear material, - nuclear fuel fabrication, - reactors, - critical facilities, - reprocessing of nuclear fuel, - processing (not including repackaging or conditioning not involving the separation of elements, for storage or disposal) of intermediate or high-level waste containing plutonium, high enriched uranium or uranium-233, but do not include activities related to theoretical or basic scientific research or to research and development on industrial radioisotope applications, medical, hydrological and agricultural applications, health and environmental effects and improved maintenance.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Multiregional Modeling Working Group or “MMWG” shall mean the NERC working group that is charged with multi-regional modeling.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Step therapy means a protocol or

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Development Program means the implementation of the development plan.

  • Pivotal Clinical Trial means, with respect to a Licensed Product, (a) a phase 3 Clinical Trial or (b) any other clinical trial that is intended (as of the time the study is initiated) to obtain the results and data to support (without the need to conduct any additional clinical trial) the filing of an application for Regulatory Approval for such product.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Step therapy protocol means a protocol or program that establishes the specific

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • site development plan means a dimensioned plan drawn to scale that indicates details of the proposed land development, including the site layout, positioning of buildings and structures, property access, building designs and landscaping;

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Commercial driver s license" means:

  • Radiation therapy simulation system means a radiographic or fluoroscopic x-ray system intended for localizing the volume to be exposed during radiation therapy and confirming the position and size of the therapeutic irradiation field.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.